BSE filing, NSE: KREBSBIO. Summary written from the filing by ALFA Finder's alert engine.
Krebs Biochemicals & Industries Ltd: key numbers
- Share price
- ₹59.15
- Market cap
- ₹127.5 Cr
- Revenue (annual)
- ₹23.73 Cr
- Net profit (annual)
- ₹-16.93 Cr
- P/E (TTM)
- -9.1×Sector 46.1×
- Promoter holding
- 72.74%+0.00% QoQ
- FII holding
- 0.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krebs Biochemicals & Industries Ltd
All →Krebs Biochemicals & Industries Board Meeting Date
Krebs Biochemicals & Industries Limited has scheduled a board meeting for October 29, 2026. The board will consider and adopt unaudited financial results for the second quarter.
Krebs Biochemicals & Industries Other Announcement
Krebs Biochemicals & Industries Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations, disclosing the distribution of equity stakes among shareholders.
Krebs Biochemicals & Industries Annual General Meeting
Krebs Biochemicals & Industries Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of FY2025-26 audited financials and related party transactions.
Krebs Biochemicals & Industries Annual General Meeting
Krebs Biochemicals and Industries Limited has issued a notice for its 34th Annual General Meeting scheduled for September 29, 2026. Key agenda items include the approval of financial statements and related party transactions.
Krebs Biochemicals & Industries Annual Report
Krebs Biochemicals & Industries Limited has submitted its 34th Annual Report for the financial year 2025-26. The report includes financial highlights, directors' report, and audited financial statements.
Krebs Biochemicals & Industries Q1 FY27 Results: Net Loss of ₹2.5 Cr, Loss Narrows
Krebs Biochemicals & Industries Ltd reported revenue from operations of ₹7 Cr (+27.3% YoY) and a net loss of ₹2.5 Cr for Q1 FY27.
- Key figure
- Net loss ₹2.5 Cr
Other board meeting date announcements
All →Rajasthan Cylinders & Containers Board Meeting Date
Rajasthan Cylinders & Containers intimated a board meeting on 05 November 2026 to approve unaudited results for quarter and half year ended 30 September 2026. The trading window stays closed until 07 November 2026.
Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.